BackVBI Vaccines Overview

VBI Vaccines Total Revenue

Revenue analysis for VBIV.

Quarterly Revenue

$1.21M
↑ 150.31% YoY

As of Mar 2024

Annual Revenue (TTM)

$9.41M
↑ 553.09% YoY

Trailing 12 months ending Mar 2024

Average Revenue (Comparison Companies)

Loading

Total Revenue History

Loading

Total Revenue Comparison

Loading

Annual Revenue Growth Rate (%)

Loading

Annual Revenue Growth (Absolute)

Loading
Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin